Ë¿¹ÏÊÓÆµ

White Paper

IVDR Regulation for EU


Free White Paper

Impact Assessment of Revision of the Ë¿¹ÏÊÓÆµ Framework for Ë¿¹ÏÊÓÆµ Directive in EU

Inside this White Paper

The transition from the Ë¿¹ÏÊÓÆµ Directive (MDD) to the In Vitro Diagnostic Regulation (IVDR) represents a significant shift in the European regulatory landscape for medical devices. This white paper from Ë¿¹ÏÊÓÆµ Compliance Associates® provides an in-depth analysis of the changes introduced by the IVDR, including enhanced oversight of Notified Bodies, stricter post-market surveillance requirements, and the introduction of unique device identification (UDI) systems. It also addresses the challenges manufacturers may face during this transition and offers strategic guidance to ensure compliance. Whether you’re a manufacturer, importer, or distributor, this resource is essential for understanding the new regulatory requirements and maintaining market access in the EU.

Learn more about our Compliance Assurance and Ë¿¹ÏÊÓÆµ Affairs services and how RCA can help you ensure you get your product to market quick and efficiently.

Register to Read the Whitepaper

    Begin the Ë¿¹ÏÊÓÆµ Compliance Associates Scoping Process Today

    Contact Us